Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Gastroenterology

Pharmacology/kinetics

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet: Gastroenterology & Hepatology | May 12, 2021 Pharmacology/kinetics

Chemotherapy alone vs definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: A population-based study

BMC Gastroenterology | Apr 13, 2021 Pharmacology/kinetics

Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: A network meta-analysis

Gastroenterology | Apr 12, 2021 Pharmacology/kinetics

Saroglitazar, a PPAR‐α/γ agonist, for treatment of nonalcoholic fatty liver disease: A randomized controlled double‐blind phase 2 trial

Hepatology | Apr 08, 2021 Pharmacology/kinetics

The risk of epilepsy after long-term proton pump inhibitor therapy

Seizure - European Journal of Epilepsy | Mar 17, 2021 Pharmacology/kinetics

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes

Metabolism | Mar 16, 2021 Pharmacology/kinetics

Major GI bleeding in older persons using aspirin: Incidence and risk factors in the ASPREE randomised controlled trial

Gut | Mar 15, 2021 Pharmacology/kinetics

Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis

Nutrition, Metabolism & Cardiovascular Diseases | Feb 12, 2021 Pharmacology/kinetics

Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation

Hepatology | Feb 10, 2021 Pharmacology/kinetics

Lenvatinib vs sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis

Liver International | Feb 10, 2021 Pharmacology/kinetics

« Prev 1 … 11 12 13 14 15 … 85 Next »

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Chemotherapy alone vs definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: A population-based study

Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: A network meta-analysis

Saroglitazar, a PPAR‐α/γ agonist, for treatment of nonalcoholic fatty liver disease: A randomized controlled double‐blind phase 2 trial

The risk of epilepsy after long-term proton pump inhibitor therapy

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes

Major GI bleeding in older persons using aspirin: Incidence and risk factors in the ASPREE randomised controlled trial

Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis

Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation

Lenvatinib vs sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Chemotherapy alone vs definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: A population-based study

Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: A network meta-analysis

Saroglitazar, a PPAR‐α/γ agonist, for treatment of nonalcoholic fatty liver disease: A randomized controlled double‐blind phase 2 trial

The risk of epilepsy after long-term proton pump inhibitor therapy

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes

Major GI bleeding in older persons using aspirin: Incidence and risk factors in the ASPREE randomised controlled trial

Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis

Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation

Lenvatinib vs sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Select Specialty

Select Topic